{"AllianceGenome": "11648", "HGNC": "11648", "MIM": "186960", "_id": "8115", "_version": 1, "accession": {"genomic": ["AL133467.4", "AL139020.5", "CH471061.1", "CP068264.2", "JC006894.1", "NC_000014.9", "NC_060938.1", "X82241.1"], "protein": ["AAH03574.1", "AAH05831.1", "AAH14024.1", "CAA57708.1", "CAG33077.1", "CDL93495.1", "EAW81622.1", "EAW81623.1", "NP_001092195.1", "NP_068801.1", "P56279.1"], "rna": ["BC003574.1", "BC005831.2", "BC009502.2", "BC009891.2", "BC014024.1", "BG718395.1", "BU602054.1", "CR456796.1", "NM_001098725.2", "NM_021966.3", "NR_049726.2", "X82240.1"], "translation": [{"protein": "AAH14024.1", "rna": "BC014024.1"}, {"protein": "NP_001092195.1", "rna": "NM_001098725.2"}, {"protein": "CAA57708.1", "rna": "X82240.1"}, {"protein": "NP_068801.1", "rna": "NM_021966.3"}, {"protein": "CAG33077.1", "rna": "CR456796.1"}, {"protein": "AAH05831.1", "rna": "BC005831.2"}, {"protein": "AAH03574.1", "rna": "BC003574.1"}]}, "alias": "TCL1", "ensembl": {"gene": "ENSG00000100721", "protein": ["ENSP00000385036", "ENSP00000450496", "ENSP00000450701", "ENSP00000450997", "ENSP00000451322", "ENSP00000451506", "ENSP00000451973", "ENSP00000452028"], "transcript": ["ENST00000402399", "ENST00000553467", "ENST00000554012", "ENST00000554119", "ENST00000555202", "ENST00000555886", "ENST00000556156", "ENST00000556450", "ENST00000557043"], "translation": [{"protein": "ENSP00000385036", "rna": "ENST00000402399"}, {"protein": "ENSP00000451506", "rna": "ENST00000554012"}, {"protein": "ENSP00000450701", "rna": "ENST00000556450"}, {"protein": "ENSP00000452028", "rna": "ENST00000557043"}, {"protein": "ENSP00000450997", "rna": "ENST00000554119"}, {"protein": "ENSP00000451973", "rna": "ENST00000555886"}, {"protein": "ENSP00000451322", "rna": "ENST00000556156"}, {"protein": "ENSP00000450496", "rna": "ENST00000555202"}], "type_of_gene": "protein_coding"}, "entrezgene": "8115", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 6.60570827681, "exp_mis": 56.0737287545, "exp_syn": 27.1700985656, "lof_z": 0.618866032191327, "mis_z": 0.331408847109671, "mu_lof": 4.82412374572e-07, "mu_mis": 4.94704093553e-06, "mu_syn": 2.3635702751e-06, "n_lof": 5.0, "n_mis": 51.0, "n_syn": 25.0, "p_li": 0.0012233048337285, "p_null": 0.364623682742003, "p_rec": 0.634153012424268, "syn_z": 0.258097366783338}, "bp": 345, "cds_end": 96180403, "cds_start": 96178091, "n_exons": 3, "nonpsych": {"exp_lof": 5.92027553636, "exp_mis": 50.6936090327, "exp_syn": 24.5330367072, "lof_z": 0.371448781989421, "mis_z": 0.332500302157884, "mu_lof": 4.82412374572e-07, "mu_mis": 4.94704093553e-06, "mu_syn": 2.3635702751e-06, "n_lof": 5.0, "n_mis": 46.0, "n_syn": 23.0, "p_li": 0.000931491707011503, "p_null": 0.454263567689763, "p_rec": 0.544804940603226, "syn_z": 0.194868351006455}, "nontcga": {"exp_lof": 6.07154693801, "exp_mis": 51.5821292737, "exp_syn": 24.9907905213, "lof_z": 0.428985630632679, "mis_z": 0.31785387441219, "mu_lof": 4.82412374572e-07, "mu_mis": 4.94704093553e-06, "mu_syn": 2.3635702751e-06, "n_lof": 5.0, "n_mis": 47.0, "n_syn": 22.0, "p_li": 0.000955172525927387, "p_null": 0.418544472447327, "p_rec": 0.580500355026746, "syn_z": 0.378807225817571}, "transcript": "ENST00000402399.1"}, "exons": [{"cdsend": 95714066, "cdsstart": 95711754, "chr": "14", "position": [[95709946, 95710881], [95711753, 95711802], [95712219, 95712396], [95713946, 95714125]], "strand": -1, "transcript": "NM_001098725", "txend": 95714125, "txstart": 95709946}, {"cdsend": 95714066, "cdsstart": 95711754, "chr": "14", "position": [[95709946, 95710881], [95711748, 95711802], [95712219, 95712396], [95713946, 95714125]], "strand": -1, "transcript": "NM_021966", "txend": 95714125, "txstart": 95709946}, {"cdsend": 95714125, "cdsstart": 95714125, "chr": "14", "position": [[95709946, 95710881], [95711748, 95711802], [95712219, 95712396], [95712550, 95712774], [95713946, 95714125]], "strand": -1, "transcript": "NR_049726", "txend": 95714125, "txstart": 95709946}], "exons_hg19": [{"cdsend": 96180403, "cdsstart": 96178091, "chr": "14", "position": [[96176283, 96177218], [96178090, 96178139], [96178556, 96178733], [96180283, 96180462]], "strand": -1, "transcript": "NM_001098725", "txend": 96180462, "txstart": 96176283}, {"cdsend": 96180403, "cdsstart": 96178091, "chr": "14", "position": [[96176283, 96177218], [96178085, 96178139], [96178556, 96178733], [96180283, 96180462]], "strand": -1, "transcript": "NM_021966", "txend": 96180462, "txstart": 96176283}, {"cdsend": 96180462, "cdsstart": 96180462, "chr": "14", "position": [[96176283, 96177218], [96178085, 96178139], [96178556, 96178733], [96178887, 96179111], [96180283, 96180462]], "strand": -1, "transcript": "NR_049726", "txend": 96180462, "txstart": 96176283}], "generif": [{"pubmed": 12009899, "text": "An exposed hydrophobic patch composed of two discontinuous amino acid stretches has been identified near one end of the TCL1 beta-barrel that is required for TCL1-AKT binding association."}, {"pubmed": 12127395, "text": "Increased TCL1 expression correlates with PBC-ALL progression and loss of TEL expression. TCL1 expression is important for the maturation of precursor lymphocytes but not differentiated B or T cells."}, {"pubmed": 12381789, "text": "data demonstrate that TCL1 is a powerful oncogene that, when overexpressed in both B and T cells, predominantly yields mature B cell lymphomas"}, {"pubmed": 12421830, "text": "oncogene transactivation by Sp1"}, {"pubmed": 12576313, "text": "results further support derivation of blastic tumors of skin from dendritic cells and demonstrate TCL1 proto-oncogene protein expression in this tumor"}, {"pubmed": 12672960, "text": "altered expression in Burkitt lymphomas in the presence of Epstein-Barr virus"}, {"pubmed": 15325703, "text": "Involved in the pathogenesis of mature leukemias and lymphomas: mature T-cell leukemia and chronic lymphocytic leukemia(review)"}, {"pubmed": 15459205, "text": "Akt kinase activity can be inhibited by a peptide spanning the betaA strand of the proto-oncogene TCL1"}, {"pubmed": 16002684, "text": "Detailed mechanism for TCL1-augmented signaling helps explain the delayed occurrence of mature T cell expansions and leukemias despite tumorigenic TCL1 dysregulation that begins in early thymocytes."}, {"pubmed": 17151114, "text": "In EBV-negative diffuse large B-cell lymphoma and Burkitt lymphoma-derived cell lines infected in vitro with a recombinant EBV, high expression of EBNA2 inversely correlated with expression of germinal center-associated genes, BCL6 and TCL1."}, {"pubmed": 17178851, "text": "Expression levels of microRNA generally inversely correlated with Tcl1 expression in chronic lymphocytic leukemia."}, {"pubmed": 17360849, "text": "Biological action of the proto-oncogene TCL1 family and the development avenues for a suppressive drug specific for Akt, a core intracellular survival regulator.[REVIEW]"}, {"pubmed": 17548807, "text": "TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation."}, {"pubmed": 17592280, "text": "TCL1 expression in B-cell tumors parallels its regulation in non-neoplastic B cells and can be used diagnostically as an indicator of the differentiation stage of a given B-cell tumor."}, {"pubmed": 17625607, "text": "TCL1A deregulation may be caused by faulty gene silencing as a potential consequence of losses of 7q miRNAs in splenic marginal zone lymphoma."}, {"pubmed": 17659340, "text": "Lower TCL-1 levels were associated with improved complete remission rate and progression-free survival"}, {"pubmed": 17846228, "text": "TCL1 inhibits activation-induced cell death in T cells by blocking PKCtheta and ERK activation, upon cellular activation"}, {"pubmed": 17890451, "text": "in T-cell prolymphocytic leukemia, TCL1 represents a highly regulated, targetable modulator of T cell receptor-mediated AKT growth signaling"}, {"pubmed": 18546844, "text": "mediates intracellular signals to regulate a variety of cellular responses and its genomic mutations and alterations underlie cancer, viral and/or bacterial infections.[review]"}, {"pubmed": 18820675, "text": "TCL1A expression delineates biological and clinical variability in B-cell lymphoma."}, {"pubmed": 19064921, "text": "The results indicate that Tcl1 overexpression causes B cell chronic lymphocytic leukemia by directly enhancing NF-kappaB activity and inhibiting AP-1."}, {"pubmed": 19155496, "text": "Tcl1A unique set of molecules, Tcl1 and galectin-1, defines distinct B cell receptor signaling cascades, dictating survival and death of human naive and immunoglobulin M-positive (IgM+) memory B cells."}, {"pubmed": 19480937, "text": "Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition."}, {"pubmed": 19536169, "text": "MIR34B/MIR34C regulates TCL1 expression in chronic lymphocytic leukemia"}, {"pubmed": 19668332, "text": "establish that the association between TCL1A and IkappaB is compatible with AKT binding to TCL1A, but incompatible with IkappaB binding to NF-kappaB"}, {"pubmed": 19776126, "text": "The authors confirmed that EBNA3C upregulates TCL1 and discovered that EBNA3C upregulates TCL1 through RBP-Jkappa, indicating a central role for EBNA3C interaction with RBP-Jkappa in mediating cell gene transcription."}, {"pubmed": 19889012, "text": "TCL1 mRNA expression may predict clinical outcome in CLL and that the IGHV3-21 subset, regardless of mutational status, displays high TCL1 expression."}, {"pubmed": 20357824, "text": "CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation."}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20382409, "text": "TCL1 positivity was predominantly found in germinal center phenotype diffuse large B-cell lymphoma."}, {"pubmed": 20395523, "text": "Immunohistochemical evaluation of TCL1 expression may be useful for substantiating a diagnosis of unclassified type of intratubular germ cell neoplasia or seminoma."}, {"pubmed": 20553335, "text": "TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma."}, {"pubmed": 20876420, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21130495, "text": "Data indicate an inverse correlation between miR-16-1, miR-181a, miR-181b, and level of expression of TCL-1 and BCL-2, which suggest that these miRNAs may implicate in negatively regulating target mRNA at transcriptional level."}, {"pubmed": 21172079, "text": "This study identified 4 single nucleotide polymorphisms related to TCL1A that, when present, were associated with musculoskeletal adverse effects to anastrozole or exemestane treatment in postmenopausal women with stage I to III breast cancer."}, {"pubmed": 22001392, "text": "Using primary chronic lymphocytic leukemia cells we have shown an inverse relationship between TCL1 and PTPROt expression."}, {"pubmed": 22189846, "text": "genetic association studies in a Japanese population: Data suggest that a substantial number of patients with T-cell prolymphocytic leukemia exhibit abnormal expression of TCL1A probably due to rearrangement in region of TCL1 gene."}, {"pubmed": 22308499, "text": "CLL samples with high Tcl1 expression showed a decrease in DNA methylation compared with CLL samples with low Tcl1 expression"}, {"pubmed": 22405131, "text": "SNPs near the 3' terminus of TCL1A were associated with aromatase inhibitors-dependent musculoskeletal pain. Estradiol induced SNP-dependent TCL1A expression."}, {"pubmed": 22448662, "text": "100% of dysgerminomas were positive for TCL1, but all immature teratomas were negative."}, {"pubmed": 22460735, "text": "These findings demonstrate that the microenvironment has a proactive role in the regulation of the known signaling enhancer and pro-survival molecule TCL1 in CLL."}, {"pubmed": 22553924, "text": "Data indicate that up-regulated transcription of TCL1A was observed in two cases."}, {"pubmed": 22645177, "text": "TCL1 is hyperexpressed in multiple B-cell lymphomas."}, {"pubmed": 22674796, "text": "Intracellular expression of the TCL1 as well as membrane and intracellular expression of ILT7 in plasmacytoid dendritic cell leukemia (pDCL) samples and 61 non-pDC acute leukemia samples, were tested."}, {"pubmed": 22875623, "text": "TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q."}, {"pubmed": 23160471, "text": "Our findings reveal a functional interaction between Tcl1 and Hsp70 and identify Tcl1 as a novel Hsp70 client protein"}, {"pubmed": 23608884, "text": "TCL1-Tg:p53(-/-) leukemia cells exhibit higher survival capacity and are more drug resistant than the leukemia cells from TCL1-Tg:p53wt mice"}, {"pubmed": 24966976, "text": "Case Report: T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRgamma-TCL1A translocation] confirmed by FISH."}, {"pubmed": 25310835, "text": "Report frequent TCL1A rearrangements in T-cell prolymphocytic leukemia with cutaneous involvement."}, {"pubmed": 25348018, "text": "Peptide-based TCL1-interphase mimics were potent in steric AKT antagonization."}, {"pubmed": 25481307, "text": "Polymorphic genetic variations of cytochrome P450 19A1 and T-cell leukemia 1A genes in the Tamil population"}, {"pubmed": 25646413, "text": "demonstrated that miR-3676 targets three consecutive 28-bp repeats within 3'UTR of TCL1 and showed that miR-3676 is a powerful inhibitor of TCL1"}, {"pubmed": 25688912, "text": "Our study suggests that TCL1 expression profile may have a role in the prediction of overall outcome in patient with MCL and call for prospective studies."}, {"pubmed": 25936528, "text": "High TCL1A expression is associated with chronic lymphocytic leukemia."}, {"pubmed": 26090867, "text": "Suggest miR-181b as therapeutic target for chronic lymphocytic leukemia in the Emicro-TCL1 mouse model."}, {"pubmed": 26299617, "text": "Our results suggest that intratumoral TCL1A+ B cells are important for controlling cervical cancer development."}, {"pubmed": 26493619, "text": "We investigated TCL1 expression at the protein level in the bone marrow of a series of 59 patients with Waldenstrom macroglobulinemia: 76% of patients expressed TCL1, which appeared to be associated with a pejorative prognostic impact."}, {"pubmed": 28178623, "text": "TCL1A is not only a useful biomarker for prognostic evaluation in stage II/III colorectal cancer patients."}, {"pubmed": 28232160, "text": "Case Report:  hematogones can express TCL-1 in patients with T-cell prolymphocytic leukemia after therapy."}, {"pubmed": 29048125, "text": "TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line."}, {"pubmed": 29449575, "text": "Combination of T-cell lymphoma-1 protein (TCL1)-overexpression and damaging ataxia telangiectasia mutated protein (ATM) functionally synergistically contribute to T-cell prolymphocytic leukemia (T-PLL) specific phenotype of impaired DNA damage processing."}, {"pubmed": 29592948, "text": "TCL1A also acts as a transcriptional coregulator with NF-kappaB p65"}, {"pubmed": 33301031, "text": "Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling."}, {"pubmed": 33760860, "text": "Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer."}, {"pubmed": 34206047, "text": "TCL1A, B Cell Regulation and Tolerance in Renal Transplantation."}, {"pubmed": 36317339, "text": "TCL1A acts as a tumour suppressor by modulating gastric cancer autophagy via miR-181a-5p-TCL1A-Akt/mTOR-c-MYC loop."}, {"pubmed": 37023372, "text": "Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia."}, {"pubmed": 37046083, "text": "Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis."}], "genomic_pos": {"chr": "14", "end": 95714196, "ensemblgene": "ENSG00000100721", "start": 95709947, "strand": -1}, "genomic_pos_hg19": {"chr": "14", "end": 96180533, "start": 96176304, "strand": -1}, "go": {"BP": {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035556", "pubmed": 10983986, "qualifier": "involved_in", "term": "intracellular signal transduction"}, "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005783", "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16189514, 16934922, 19064921, 21516116, 25416956, 25910212, 26871637, 27107012, 29997244, 31515488, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019901", "pubmed": 10983986, "qualifier": "enables", "term": "protein kinase binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042802", "pubmed": 10983986, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [25416956, 32296183], "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0043539", "qualifier": "enables", "term": "protein serine/threonine kinase activator activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0043539", "pubmed": 10983986, "qualifier": "enables", "term": "protein serine/threonine kinase activator activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0043539", "pubmed": 10983986, "qualifier": "enables", "term": "protein serine/threonine kinase activator activity"}]}, "homologene": {"genes": [[9544, 703349], [9598, 741380], [9606, 8115], [9913, 506540], [10090, 21432], [10116, 690575]], "id": 7565}, "interpro": [{"desc": "TCL1/MTCP1", "id": "IPR004832", "short_desc": "TCL1_MTCP1"}, {"desc": "TCL1/MTCP1 superfamily", "id": "IPR036672", "short_desc": "TCL1_MTCP1_sf"}], "ipi": "IPI00178749", "map_location": "14q32.13", "name": "TCL1 family AKT coactivator A", "other_names": ["T cell leukemia/lymphoma 1A", "T-cell leukemia/lymphoma protein 1A", "T-cell lymphoma-1", "oncogene TCL-1", "oncogene TCL1", "protein p14 TCL1"], "pantherdb": {"HGNC": "11648", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1097166", "ortholog_type": "LDO", "panther_family": "PTHR14060", "taxid": 10090, "uniprot_kb": "P56280"}, {"RGD": "1594686", "ortholog_type": "LDO", "panther_family": "PTHR14060", "taxid": 10116, "uniprot_kb": "D3ZWG3"}, {"Ensembl": "ENSGALG00000038681", "ortholog_type": "O", "panther_family": "PTHR14060", "taxid": 9031, "uniprot_kb": "A0A1D5PHR7"}], "uniprot_kb": "P56279"}, "pathway": {"kegg": {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, "netpath": {"id": "Pathway_BCR", "name": "BCR"}, "wikipathways": [{"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}]}, "pdb": "1JSG", "pfam": "PF01840", "pharmgkb": "PA36400", "pharos": {"target_id": 12737, "tdl": "Tbio"}, "pir": "I38286", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF258339", "relationship": "is"}, {"id": "GNF258340", "relationship": "is"}, {"id": "GNF258341", "relationship": "is"}, {"id": "GNF258342", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF163540", "relationship": "similar to"}, "GNF_hs-Origene": {"id": "GNF045596", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF091353", "relationship": "is"}, {"id": "GNF091354", "relationship": "is"}, {"id": "GNF091355", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054637", "relationship": "is"}, {"id": "GNF059415", "relationship": "is"}, {"id": "GNF074802", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070953", "relationship": "is"}, {"id": "GNF070954", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF014396", "relationship": "is"}, {"id": "GNF014397", "relationship": "is"}, {"id": "GNF014398", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF284357", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF106605", "relationship": "is"}, {"id": "GNF146251", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000014.9", "NC_060938.1"], "protein": ["NP_001092195.1", "NP_068801.1"], "rna": ["NM_001098725.2", "NM_021966.3", "NR_049726.2"], "translation": [{"protein": "NP_068801.1", "rna": "NM_021966.3"}, {"protein": "NP_001092195.1", "rna": "NM_001098725.2"}]}, "reporter": {"HG-U133_Plus_2": ["209995_s_at", "39318_at"], "HG-U95Av2": "39318_at", "HTA-2_0": "TC14001478.hg.1", "HuEx-1_0": "3578152", "HuGene-1_1": "7981183", "HuGene-2_1": "16796451"}, "summary": "Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene in close proximity to the T-cell antigen receptor (TCR)-alpha (MIM 186880) or TCR-beta (MIM 186930) regulatory elements (summarized by Virgilio et al., 1998 [PubMed 9520462]). In normal T cells TCL1 is expressed in CD4-/CD8- cells, but not in cells at later stages of differentiation. TCL1 functions as a coactivator of the cell survival kinase AKT (MIM 164730) (Laine et al., 2000 [PubMed 10983986]).[supplied by OMIM, Jul 2010].", "symbol": "TCL1A", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420650"}, "unigene": "Hs.2484", "uniprot": {"Swiss-Prot": "P56279", "TrEMBL": ["H0YJR9", "G3V4T4"]}, "wikipedia": {"url_stub": "TCL1A"}}